| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/11/2001 | WO2001075146A1 Diagnosis of autoimmune disease |
| 10/11/2001 | WO2001075145A2 Ubiquitin ligase assay |
| 10/11/2001 | WO2001075143A2 Sigma binding region of rna polymerase and uses thereof |
| 10/11/2001 | WO2001075141A2 Biosensor chip |
| 10/11/2001 | WO2001075135A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/11/2001 | WO2001075074A1 Novel proteins |
| 10/11/2001 | WO2001075064A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 10/11/2001 | WO2001074904A2 G-protein coupled receptors and nucleic acids encoding same |
| 10/11/2001 | WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF |
| 10/11/2001 | WO2001074899A1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
| 10/11/2001 | WO2001074896A1 Human polynucleotides, polypeptides, and antibodies |
| 10/11/2001 | WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 10/11/2001 | WO2001074842A1 Macromolecule detection |
| 10/11/2001 | WO2001074838A1 Dna molecules encoding l-glutamate-gated chloride channels from rhipicephalus sanguineus |
| 10/11/2001 | WO2001074837A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 10/11/2001 | WO2001074470A1 Apparatus for cleaning and analyzing debris from oil filters |
| 10/11/2001 | WO2001074359A1 Sigma receptor ligands and their medical uses |
| 10/11/2001 | WO2001074298A2 Methods and compositions for regulating memory consolidation |
| 10/11/2001 | WO2001074242A2 Capillary flow control in a medical diagnostic device |
| 10/11/2001 | WO2001074164A1 Methods of modulating hair growth |
| 10/11/2001 | WO2001074159A2 Systems and methods for collecting plasma that is free or virtually free of cellular blood species |
| 10/11/2001 | WO2001074158A2 Systems and methods for collecting leukocyte-reduced blood components, including plasma that is free or virtually free of cellular blood species |
| 10/11/2001 | WO2001074151A1 Milk sampling apparatus and method |
| 10/11/2001 | WO2001074149A1 Milk sampling apparatus and method |
| 10/11/2001 | WO2001074130A2 A computer based method for identifying conserved invariant peptide motifs |
| 10/11/2001 | WO2001066139A8 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell |
| 10/11/2001 | WO2001042781A9 Supracolonic aerodigestive neoplasm detection |
| 10/11/2001 | WO2001038583A3 Capillary array-based sample screening |
| 10/11/2001 | WO2001036640A3 Human fgf-21 gene and gene expression products |
| 10/11/2001 | WO2001032702A9 Molecular structure of rhd negative locus |
| 10/11/2001 | WO2001031003B1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 10/11/2001 | WO2001027612A3 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool |
| 10/11/2001 | WO2001025269A3 Human g-protein coupled receptor |
| 10/11/2001 | WO2001022083A3 Method for identifying mhc-restricted antigens |
| 10/11/2001 | WO2001021799B1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 10/11/2001 | WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 10/11/2001 | WO2001020025A3 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 10/11/2001 | WO2001020021A3 Complex with specific dephosphorylating enzymes, effectors and method for the production of said complex. |
| 10/11/2001 | WO2001014590A3 Simultaneous isolation and quantitation of dna |
| 10/11/2001 | WO2001009373A3 NATIVE Cdc25 SUBSTRATES, COMPOSITIONS AND USES RELATED THERETO |
| 10/11/2001 | WO2001007625A3 Ehrlichia canis genes and vaccines |
| 10/11/2001 | WO2001007470A3 Human nervous system-associated proteins |
| 10/11/2001 | WO2001003573A3 Method of diagnosis of cardiac hypertrophy |
| 10/11/2001 | WO2000070322A3 A-FORM OF CYTOPLASMIC DOMAIN OF nARIA (CRD-NEUREGULIN) AND USES THEREOF |
| 10/11/2001 | WO2000066773A3 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents |
| 10/11/2001 | WO2000063382A9 Genes and expression products from hematopoietic cells |
| 10/11/2001 | WO2000055364A3 Genetic analysis |
| 10/11/2001 | WO2000054053A9 Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses |
| 10/11/2001 | WO2000050633A9 Method for cloning signal transduction intermediates |
| 10/11/2001 | WO2000049413A9 Rapid assay for arthropod-borne disease vectors and pathogens |
| 10/11/2001 | WO2000044932A9 Homogeneous enzymatic assay for vitamin b6 |
| 10/11/2001 | WO2000041472A3 Binding partners for 5-ht5-receptors for the treatment of migraine |
| 10/11/2001 | WO2000030628A3 Method of inhibiting angiogenesis |
| 10/11/2001 | WO2000026248A3 Tuberculosis diagnostic test |
| 10/11/2001 | WO2000005578A3 Method for labelling solid support bound compounds |
| 10/11/2001 | WO1999058969A3 Automatic determination of the contamination of aqueous cleaning solutions with carbonaceous compounds |
| 10/11/2001 | US20010029617 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 10/11/2001 | US20010029340 Indirect calorimeter for medical applications |
| 10/11/2001 | US20010029339 Apparatus and method for non-invasively measuring cardiac output |
| 10/11/2001 | US20010029320 Apparatus and method for electophysiological testing |
| 10/11/2001 | US20010029295 Isolated polynucleotide |
| 10/11/2001 | US20010029293 Icam-related protein |
| 10/11/2001 | US20010029246 Antiproliferative agent |
| 10/11/2001 | US20010029050 Sensing system for specific substance and molecule detection |
| 10/11/2001 | US20010029049 Comprising a substrate with a surface comprising discrete sites, a population of microspheres comprising first and second subpopulaton, which comprising reporter dye, emits optical response when subjected to activation light energy |
| 10/11/2001 | US20010029048 Simultaneous multianalyte electrochemical assay based on spatial resolution |
| 10/11/2001 | US20010029043 Prokaryotic; transformed with nucleic acid encoding papillomavirus virus major capsid protein that assembles within, such as Salmonella, to form chimeric virus like particles; anticancer, antitumor vaccine |
| 10/11/2001 | US20010029031 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 10/11/2001 | US20010029030 Novel trail receptors, nucleic acids encoding same, and methods of use thereof |
| 10/11/2001 | US20010029027 Incubating mixture comprising proteoglycan, LDL, candidate compound, determining difference between amount complex in mixture without compound |
| 10/11/2001 | US20010029026 In library, maximizing design objective by examining each variation site in alternating sequence; each candidate reagent subarray is evaluated by constructing and ranked according to fitness |
| 10/11/2001 | US20010029025 Method of identifying proteins |
| 10/11/2001 | US20010029024 Selection of peptides with antibody-like properties |
| 10/11/2001 | US20010029023 Placing modified bacteria, that produces detectable light emission signals, on side of material; determining presence of signal on second side or withinmaterial; sutures, dental fillings |
| 10/11/2001 | US20010029020 In vitro determination of metastatic stomach, esophageal, and colorectal cancer from sampling cells outside of the colorectal track for gene transcript or protein |
| 10/11/2001 | US20010029019 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 10/11/2001 | US20010029016 Detection of alcaline isophosphatases by electrophoresis |
| 10/11/2001 | US20010029014 Methods and kits for identifying elite event GAT-ZM1 in biological samples |
| 10/11/2001 | US20010028881 Determination concentrtaion |
| 10/11/2001 | US20010028878 Culture product |
| 10/11/2001 | US20010028875 Screening methods for gram-positive enterococcal virulence factors |
| 10/11/2001 | US20010028459 Method of measuring the quality properties of paper and/or board on moving webs |
| 10/11/2001 | US20010027949 Rapid characterization of polymers for combinatorial, analytical and process control applications |
| 10/11/2001 | US20010027927 Such as trinitrotoluene or nitrotoluene derivatives, or chemical warfare agents, using measurement cycles at different current strengths, where electrolyte is applied as thin layer on surface of sensor element; efficient detection |
| 10/11/2001 | US20010027679 Gas sensor having improved structure for installation of protective cover |
| 10/11/2001 | US20010027678 Apparatus and methods relating to humidified air and to sensing components of gas or vapour |
| 10/11/2001 | EP1144996A3 Automatic determination of the contamination of aqueous cleaning solutions with carbonaceous compounds |
| 10/11/2001 | EP1144994A3 Method for labelling solid support bound compounds |
| 10/11/2001 | EP1144679A3 Capillary array-based sample screening |
| 10/11/2001 | EP1144447A3 Tuberculosis diagnostic test |
| 10/11/2001 | DE10065384A1 Gas sensor for internal combustion engine, has sensing element and protector covered by protective cap with tabular support and exhaust hole |
| 10/11/2001 | DE10017790A1 Verfahren zur Herstellung von Biopolymer-Feldern mit Echtzeitkontrolle A process for the production of biopolymer fields with real-time control |
| 10/11/2001 | DE10017249A1 Highly sensitive detection of malignant tumors, comprises immunological determination of RiV particles using specific antibodies |
| 10/11/2001 | DE10017105A1 Verfahren und Vorrichtung zur Herstellung von Biopolymer-Feldern Method and apparatus for the production of biopolymer fields |
| 10/11/2001 | DE10015587A1 Measuring, warning and protection system serving as safeguard against pollution of rivers with toxic industrial agents comprises fixed stations which communicate with mobile observation units |
| 10/11/2001 | DE10015448A1 Detection and quantification of binding between affinity molecules useful in screening for drugs, does not require removal of reaction solution prior to measurement |
| 10/11/2001 | DE10015284A1 Prognosis and therapy control of colorectal cancer, useful e.g. for deciding on chemotherapeutic adjuvant treatment, by measuring amount of sialyl-Lewis antigen x |
| 10/11/2001 | DE10013794A1 Herstellung, Stabilisierung und Anwendung einer neuen Art von chemisch aktivierten Oberflächen Production, stabilization and application of a new type of chemically activated surfaces |
| 10/11/2001 | DE10013619A1 New polypeptide subunit of invertebrate ligand-controlled anion channel, useful in screening for potential plant-protection agents, especially insecticides |
| 10/11/2001 | DE10013240A1 Anordnung zu kontaminationsfreier Bearbeitung von insbesondere molekularbiologischen Reaktionsabläufen, Verschlußträger und Einzelverschluß für eine solche Anordnung sowie Vorrats-und Abgabeanordnung für Einzelverschlüsse Arrangement to contamination-free processing of particular molecular biological reaction processes, bolt carrier and single lock for such an arrangement as well as supply and dispensing assembly for single closures |